1. Home
  2. HQI vs ACRV Comparison

HQI vs ACRV Comparison

Compare HQI & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HireQuest Inc. (DE)

HQI

HireQuest Inc. (DE)

HOLD

Current Price

$11.29

Market Cap

151.0M

ML Signal

HOLD

Logo Acrivon Therapeutics Inc.

ACRV

Acrivon Therapeutics Inc.

N/A

Current Price

$1.66

Market Cap

47.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HQI
ACRV
Founded
2002
2018
Country
United States
United States
Employees
65000
N/A
Industry
Professional Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.0M
47.6M
IPO Year
2008
2022

Fundamental Metrics

Financial Performance
Metric
HQI
ACRV
Price
$11.29
$1.66
Analyst Decision
Buy
Buy
Analyst Count
1
6
Target Price
$13.00
$13.00
AVG Volume (30 Days)
11.8K
906.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.29%
N/A
EPS Growth
N/A
13.14
EPS
0.34
N/A
Revenue
$34,598,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$805.34
P/E Ratio
$31.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.38
$1.05
52 Week High
$13.78
$5.65

Technical Indicators

Market Signals
Indicator
HQI
ACRV
Relative Strength Index (RSI) 41.70 48.13
Support Level $10.29 $1.49
Resistance Level $11.99 $1.86
Average True Range (ATR) 0.68 0.11
MACD -0.13 0.02
Stochastic Oscillator 10.41 51.69

Price Performance

Historical Comparison
HQI
ACRV

About HQI HireQuest Inc. (DE)

HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

Share on Social Networks: